即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 700874-71-1 | 货号 | BCP02824 |
中文名 | LY2109761 | ||
英文名 | LY2109761 | ||
中文别名 | |||
英文别名 | LY-2109761;LY 2109761; | ||
SMILES | |||
化学名称 | |||
分子式 | C26H27N5O2 | 分子量 | 441.52 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | LY2109761 treatment induces a dose-dependent low-anchorage growth inhibition of L3.6pl/GLT cells, leading to ~33% or 73% inhibition at 2 μM and 20 μM, respectively, which can be strongly enhanced when combined with gemcitabine in combination index value of 0.36581. Blocking TβRI/II kinase activity with LY2109761 (5 μM) completely suppresses both the basal and TGF-β1-stimulated migration and invasion of L3.6pl/GLT cells, significantly enhances the detachment-induced apoptosis by 26% at 8 hours treatment, and completely suppresses TGF-β–induced Smad2 phosphorylation.LY2109761 treatment at 1 nM is sufficient to significantly block the migration and invasion but not adhesion of hepatocellular carcinoma cells by increasing E-cadherin expression.LY2109761 pretreatment enhances radiosensitivity of glioblastoma cells via TGF-β signaling blockage. LY2109761 (10 μM) reduces the self-renewal and proliferation of GBM-derived cancer stem–like cells (CSLC), which can be significantly enhanced when c |
相关产品推荐
查看更多 >Tags:LY2109761 供应商,LY2109761 购买,LY2109761 生产,LY2109761 批量,LY2109761 供应,LY2109761 订购,LY2109761 采购